Protein & Cell >

2021 , Vol. 12 >Issue 11: 832 - 835

DOI: https://doi.org/10.1007/s13238-021-00847-6

COMMENTARY

Convergent evolution of SARS-CoV-2 in human and animals

  • Hang-Yu Zhou 1,2 ,
  • Cheng-Yang Ji 1,2 ,
  • Hang Fan 3 ,
  • Na Han 1,2 ,
  • Xiao-Feng Li 3 ,
  • Aiping Wu , 1,2 ,
  • Cheng-Feng Qin , 3
Expand
  • 1. Center for Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China
  • 2. Suzhou Institute of Systems Medicine, Suzhou 215123, China
  • 3. State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing 100071, China

Accepted date: 06 Apr 2021

Published date: 15 Nov 2021

Copyright

2021 The Author(s)
Fold

Cite this article

Hang-Yu Zhou , Cheng-Yang Ji , Hang Fan , Na Han , Xiao-Feng Li , Aiping Wu , Cheng-Feng Qin . Convergent evolution of SARS-CoV-2 in human and animals[J]. Protein & Cell, 2021 , 12(11) : 832 -835 . DOI: 10.1007/s13238-021-00847-6

References

Publishing order | Descend order by publishing year | Descend order by cited within
1
Cockrell AS, Yount BL, Scobey T, Jensen K, Douglas M, Beall A,Tang X-C, Marasco WA,Heise MT, Baric RS (2016) A mouse model for MERS coronavirus-induced acute respiratory distress syndrome. Nat Microbiol 2:1–11

DOI

2
Chinese SARS Molecular Epidemiology Consortium (2004) Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 303:1666–1669

DOI

3
Davies NG, Barnard RC, Jarvis CI, Kucharski AJ, Munday J, Pearson CA, Russell TW, Tully DC, Abbott S, Gimma A (2020) Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England. medRxiv.

4
Elbe S, Buckland-Merrett G (2017) Data, disease and diplomacy: GISAID’s innovative contribution to global health. Glob Chall 1:33–46

DOI

5
Grubaugh ND, Petrone ME, Holmes EC (2020) We shouldn’t worry when a virus mutates during disease outbreaks. Nat Microbiol 5:529–530

DOI

6
Gu H, Chen Q, Yang G, He L, Fan H, Deng Y-Q, Wang Y, Teng Y, Zhao Z, Cui Y (2020) Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy. Science 369:1603–1607

DOI

7
Leist SR, Dinnon KH III, Schäfer A, Longping VT, Okuda K, Hou YJ, West A, Edwards CE, Sanders W, Fritch EJ (2020) A mouseadapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice. Cell 183:1070–1085

DOI

8
Munnink BBO, Sikkema RS, Nieuwenhuijse DF, Molenaar RJ, Munger E, Molenkamp R, Van Der Spek A, Tolsma P, Rietveld A, Brouwer M (2020) Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans. Science 371:172–177

DOI

9
Roberts A, Deming D, Paddock CD, Cheng A, Yount B, Vogel L,Herman BD, Sheahan T,Heise M, Genrich GL (2007) A mouseadapted SARS-coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog 3:e5

DOI

10
Shu Y, McCauley J (2017) GISAID: global initiative on sharing all influenza data–from vision to reality. Eurosurveillance 22:30494

DOI

11
Starr TN, Greaney AJ, Hilton SK, Ellis D, Crawford KH, Dingens AS, Navarro MJ, Bowen JE, Tortorici MA, Walls AC (2020) Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell 182:1295–1310

DOI

12
Sun S, Gu H, Cao L, Chen Q, Yang G, Li R-T, Fan H, Ye Q, Deng Y-Q, Song X (2020) Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2. bioRxiv.

DOI

13
Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, Doolabh D,Pillay S, San EJ, Msomi N (2020) Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv.

DOI

Options
Outlines

/

〈 〉